Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014

BACKGROUND: The global epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is heterogeneous. The objective of this study was to evaluate MRSA epidemiology in Switzerland over an 11-year period. METHODS: We conducted a retrospective study with time series analysis on S. aur...

Full description

Bibliographic Details
Main Authors: Flaminia Olearo, Werner C. Albrich, Nathalie Vernaz, Stephan Harbarth, Andreas Kronenberg, Swiss Centre for Antibiotic resistance (ANRESIS)
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2016-09-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/2220
_version_ 1811194363101839360
author Flaminia Olearo
Werner C. Albrich
Nathalie Vernaz
Stephan Harbarth
Andreas Kronenberg
Swiss Centre for Antibiotic resistance (ANRESIS)
author_facet Flaminia Olearo
Werner C. Albrich
Nathalie Vernaz
Stephan Harbarth
Andreas Kronenberg
Swiss Centre for Antibiotic resistance (ANRESIS)
author_sort Flaminia Olearo
collection DOAJ
description BACKGROUND: The global epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is heterogeneous. The objective of this study was to evaluate MRSA epidemiology in Switzerland over an 11-year period. METHODS: We conducted a retrospective study with time series analysis on S. aureus including MRSA and non-multidrug resistant MRSA (NmMRSA). We used NmMRSA as a marker for community-acquired MRSA. NmMRSA was defined as MRSA susceptible to at least three of the following agents: ciprofloxacin, clindamycin, tetracycline and trimethoprim-sulfamethoxazole. RESULTS: A total of 14 648 MRSA and 115 917 methicillin-susceptible S. aureus (MSSA) isolates were included. Despite an overall decrease of the proportion of MRSA among S. aureus clinical isolates (from 14% in 2004 to 8% in 2014), an increasing trend in NmMRSA was observed. Variations in geographical distribution were noted, with a decrease in the proportion of MRSA in the Italian- and French-speaking regions (from 20–26% in 2004 to 12% in 2014) and low prevalence (3–5%) in the German-speaking region. We noticed an increase in the proportion of MRSA in outpatients (+0.03% per quarter per year) and in the younger population (+0.05% per quarter per year) compared with a decreasing trend in inpatients and the elderly. CONCLUSION: The proportion of MRSA among S. aureus isolates in Switzerland decreased overall from 2004 to 2014. Worrisome increases of NmMRSA were found in younger persons and outpatients.
first_indexed 2024-04-12T00:24:26Z
format Article
id doaj.art-9394ca32ad27401291433a9024c1560b
institution Directory Open Access Journal
issn 1424-3997
language English
last_indexed 2024-04-12T00:24:26Z
publishDate 2016-09-01
publisher SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
record_format Article
series Swiss Medical Weekly
spelling doaj.art-9394ca32ad27401291433a9024c1560b2022-12-22T03:55:34ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972016-09-01146373810.4414/smw.2016.14339Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014Flaminia OlearoWerner C. AlbrichNathalie VernazStephan HarbarthAndreas KronenbergSwiss Centre for Antibiotic resistance (ANRESIS) BACKGROUND: The global epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is heterogeneous. The objective of this study was to evaluate MRSA epidemiology in Switzerland over an 11-year period. METHODS: We conducted a retrospective study with time series analysis on S. aureus including MRSA and non-multidrug resistant MRSA (NmMRSA). We used NmMRSA as a marker for community-acquired MRSA. NmMRSA was defined as MRSA susceptible to at least three of the following agents: ciprofloxacin, clindamycin, tetracycline and trimethoprim-sulfamethoxazole. RESULTS: A total of 14 648 MRSA and 115 917 methicillin-susceptible S. aureus (MSSA) isolates were included. Despite an overall decrease of the proportion of MRSA among S. aureus clinical isolates (from 14% in 2004 to 8% in 2014), an increasing trend in NmMRSA was observed. Variations in geographical distribution were noted, with a decrease in the proportion of MRSA in the Italian- and French-speaking regions (from 20–26% in 2004 to 12% in 2014) and low prevalence (3–5%) in the German-speaking region. We noticed an increase in the proportion of MRSA in outpatients (+0.03% per quarter per year) and in the younger population (+0.05% per quarter per year) compared with a decreasing trend in inpatients and the elderly. CONCLUSION: The proportion of MRSA among S. aureus isolates in Switzerland decreased overall from 2004 to 2014. Worrisome increases of NmMRSA were found in younger persons and outpatients. https://www.smw.ch/index.php/smw/article/view/2220bacteremiaMRSAMSSANonmultidrug-MRSAtimes series analysistrend
spellingShingle Flaminia Olearo
Werner C. Albrich
Nathalie Vernaz
Stephan Harbarth
Andreas Kronenberg
Swiss Centre for Antibiotic resistance (ANRESIS)
Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
Swiss Medical Weekly
bacteremia
MRSA
MSSA
Nonmultidrug-MRSA
times series analysis
trend
title Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
title_full Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
title_fullStr Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
title_full_unstemmed Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
title_short Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
title_sort staphylococcus aureus and methicillin resistance in switzerland regional differences and trends from 2004 to 2014
topic bacteremia
MRSA
MSSA
Nonmultidrug-MRSA
times series analysis
trend
url https://www.smw.ch/index.php/smw/article/view/2220
work_keys_str_mv AT flaminiaolearo staphylococcusaureusandmethicillinresistanceinswitzerlandregionaldifferencesandtrendsfrom2004to2014
AT wernercalbrich staphylococcusaureusandmethicillinresistanceinswitzerlandregionaldifferencesandtrendsfrom2004to2014
AT nathalievernaz staphylococcusaureusandmethicillinresistanceinswitzerlandregionaldifferencesandtrendsfrom2004to2014
AT stephanharbarth staphylococcusaureusandmethicillinresistanceinswitzerlandregionaldifferencesandtrendsfrom2004to2014
AT andreaskronenberg staphylococcusaureusandmethicillinresistanceinswitzerlandregionaldifferencesandtrendsfrom2004to2014
AT swisscentreforantibioticresistanceanresis staphylococcusaureusandmethicillinresistanceinswitzerlandregionaldifferencesandtrendsfrom2004to2014